Abstract Details
|
Clemens R. Scherzer, MD
(Brigham and Women'S Hospital/Harvard Medical School)
PRESENTER |
Dr. Scherzer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Scherzer has received research support from NIH. The institution of Dr. Scherzer has received research support from Michael J. Fox Foundation. The institution of Dr. Scherzer has received research support from American Parkinson's Disease Association. Dr. Scherzer has received intellectual property interests from a discovery or technology relating to health care. |
| Brendon P. Boot, MD, MBBS (BlueRock Therapeutics) | Dr. Boot has received personal compensation for serving as an employee of BlueRock Therapeutics. Dr. Boot has stock in Eyepoint Pharmaceuticals. |
| No disclosure on file | |
| Zhixiang Liao | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Xianjun Dong, PhD (Brigham and Women's Hospital) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Caroline M. Tanner, MD, PhD, FAAN (University of California San Francisco, Weill Institute for Neurosciences) | Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND. |
| Anthony E. Lang, MD, FAAN (Toronto Western Hospital) | Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| No disclosure on file | |
| Ganqiang Liu, PhD (Sun Yat-Sen University) | No disclosure on file |
| Lewis R. Sudarsky, MD | No disclosure on file |
| Alexis Elbaz, MD (INSERM U708) | No disclosure on file |
| Alexis Brice, MD | Dr. Brice has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for ICM. |
| Bernard M. Ravina, MD, MSCE (Voyager Therapeutics, Inc.) | Dr. Ravina has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Ravina has stock in Praxis. |
| Ira Shoulson, MD (University of Rochester) | Dr. Shoulson has received research support from Vaccinex. |
| J.J. Van Hilten (Duphar Nederland BV) | No disclosure on file |
| No disclosure on file | |
| Jean Christophe Corvol, MD (GH Pitie Salpetriere) | No disclosure on file |
| Roger Barker, PhD (University of Cambridge) | Roger Barker, PhD has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file |